Errata Notice: Sanford Guide to Antimicrobial Therapy 2016: Print Edition Content Notices (shipped prior to 5/11/16) Antibacterial Activity Spectra (Table 4, p78): A column shift caused activity data to be displayed incorrectly for Linezolid, Tedizolid, Rifampin (combination), TMP-SMX, Fosfomycin and Metronidazole vs. Anaerobic gram-positive bacteria (the lower right quadrant of the page). A sticker is available to replace the page: http: //www.sanfor dguide.com/support/errata
When a patient comes in with a suspected infectious disease, knowledge is power. Now this knowledge is simplified, comprehensive and easy to find. The Pharmacist's Guide to Antimicrobial Therapy and Stewardship puts all the necessary information in one place, including: Evaluating potentially infected patients Identifying the infection's suspected source and related organisms Comparing the range of anti-infectives Knowing the factors that impact treatment Developing an antimicrobial stewardship program A step-wise approach walks logically from overall key concepts to disease- and drug-specific information. Disease states are summarized for easy reference. Tables make it easy to evaluate recommended treatment options. In infectious disease management, when answers are seldom black and white, this guide helps pharmacists make confident decisions.
Covering more than 300 clinically relevant topics, Conn’s Current Therapy 2017 by Drs. Edward T. Bope and Rick D. Kellerman offers an in-depth, personal approach to treatment from international experts, ideally suited for today’s busy medical practitioners. Trustworthy and easy to use, this annually updated resource focuses solely on the most current treatment protocols for common complaints, acute diseases, and chronic illnesses you’re likely to see. New chapters and numerous new authors in this edition bring you fully up to date on the topics you need to know about for effective patient care. Reliable, in-depth, systems-based content suitable for all first-line-of-defense providers. Thorough PharmD review of recently approved and soon-to-be approved drugs. Easy access to the latest evidence-based treatment practices for the most effective results. More than 400 easy-to-understand tables make referencing complex data quick and easy. Nearly 300 images, including algorithms, anatomical illustrations, and photographs, provide useful information for diagnosis. Consult this title on your favorite e-reader, conduct rapid searches, and adjust font sizes for optimal readability. Easy access to the latest evidence-based treatment practices for the most effective results. Seven new chapters cover palliative care, pancreatic cancer, babesiosis, Zika virus, sexual dysfunction, bronchiolitis, and failure to thrive. New authors provide a fresh perspective and their personal approach to scores of conditions and topics, including arboviruses and other emerging viruses.
Prepared by residents and attending physicians at Massachusetts General Hospital, this pocket-sized looseleaf is one of the best-selling references for medical students, interns, and residents on the wards and candidates reviewing for internal medicine board exams. In bulleted lists, tables, and algorithms, Pocket Medicine provides key clinical information about common problems in internal medicine, cardiology, pulmonary medicine, gastroenterology, nephrology, hematology-oncology, infectious diseases, endocrinology, and rheumatology. This Fifth Edition is fully updated and includes a sixteen-page color insert with key and classic abnormal images. If you purchased a copy of Sabatine: Pocket Medicine 5e, ISBN 978-1-4511-8237-8, please make note of the following important correction on page 1-36: Oral anticoagulation (Chest 2012;141:e531S; EHJ 2012;33:2719; Circ 2013;127:1916) All valvular AF as stroke risk very high Nonvalv. AF: stroke risk ~4.5%/y; anticoag ® 68% ¯ stroke; use a risk score to guide Rx: CHADS2: CHF (1 point), HTN (1), Age =75 y (1), DM (1), prior Stroke/TIA (2) CHA2DS2-VASc: adds 65+74 y (1) =75 y (2), vasc dis. [MI, Ao plaque, or PAD (1)]; ? (1) score ³2 ® anticoag; score 1 ® consider anticoag or ASA (? latter reasonable if risk factor age 65-74 y, vasc dis. or ?); antithrombotic Rx even if rhythm control [SCORE CORRECTED] Rx options: factor Xa or direct thrombin inhib (non-valv only; no monitoring required) or warfarin (INR 2-3; w/ UFH bridge if high risk of stroke); if Pt refuses anticoag, consider ASA + clopi or, even less effective, ASA alone (NEJM 2009;360:2066) Please make note of this correction in your copy of Sabatine: Pocket Medicine 5e immediately and contact LWW,,s Customer Service Department at 1.800.638.3030 or 1.301.223.2300 so that you may be issued a corrected page 1-36. You may also download a PDF of page 1-36 by clicking HERE. All copies of Pocket Medicine, 5e with the ISBN: 978-1-4511-9378-7 include this correction.
New edition of highly successful annual pocket guide presenting latest information in field of antimicrobial therapy and infectious disease. Authored by leading experts in the field. Includes free access to the app.
The 2017 EMRA Antibiotic Guide, 17th ed., brings you the latest developments in the world of antibiotics, along with the return of the popular antibiogram and the introduction of a new symbol to help you quickly identify pediatric dosages.
Jones & Bartlett Learning is the Official Print and Mobile Provider of the Johns Hopkins POC-IT Center ABX Guide. Thoroughly revised and updated for 2012, the Johns Hopkins ABX Guide, Third Edition continues to provide current, authoritative and comprehensive information on anti-microbial agents, infectious disease and commonly encountered pathogens, in one portable volume. Written by experts at the world-renowned Johns Hopkins University School of Medicine, this must-have resource features expert recommendations, clinical and diagnostic decision-making tools, and drug-to-drug interactions. Concise, thorough, and current, The Johns Hopkins ABX Guide, Second Edition is designed for quick reference and comprehension. Information is featured in an easy-to-access format that facilitates rapid application of knowledge at the point of care.
Fully reviewed and revised for its second edition, the Oxford Handbook of Infectious Diseases and Microbiology maintains its position as the must-have guide to all aspects of infectious diseases and microbiology. Reflecting the current approach to joint postgraduate training programmes, the handbook takes an integrated approach to both subjects. It covers the basic principles of bacteriology and virology, along with specific guidance on individual diseases and conditions, all in the accessible Oxford Handbook style. Now including new topics on important subjects such as microbiology specimen collection, commonly used media, molecular diagnostics, and antimicrobials in pregnancy, as well as incorporating new guidelines from WHO, NICE, and BASHH among others, this handbook ensures that the informaiton you need is accessible, clear, and easy-to-understand. Practical and comprehensive, this handbook includes coverage of National Frameworks and current legislation, together with information on topical issues such as bioterrorism and preventative medicine. Fully reviewed by specialist senior readers, and with useful links to up-to-date clinical information and online resources, this is an important addition to the Oxford Handbook Series.
Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 8th Edition is the comprehensive revision of the field-leading reference on bone and mineral health. The eighth edition has been fully revised by the leading researchers and clinicians in the field to provide concise coverage of the widest possible spectrum of metabolic bone diseases and disorders of mineral metabolism. Chapters look to explain basic biological factors of healthy development and disease states and make it easily translatable to clinical interventions. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism is the definitive, one-stop reference for anyone working in the field of bone health and disease. Visit the companion site to access supplementary materials including videos, editorial team details, downloadable figures, and more.
Long considered the definitive work in its field, this new edition presents all the principles and practices readers need for a solid grounding in all aspects of clinical microbiology—bacteriology, mycology, parasitology, and virology. Tests are presented according to the Clinical and Laboratory Standards Institute (formerly NCCLS) format. This extensively revised edition includes practical guidelines for cost-effective, clinically relevant evaluation of clinical specimens including extent of workup and abbreviated identification schemes. New chapters cover the increasingly important areas of immunologic and molecular diagnosis. Clinical correlations link microorganisms to specific disease states. Over 600 color plates depict salient identification features of organisms.
Completely revised and updated for 2013, the Physicians’ Cancer Chemotherapy Drug Manual 2013 is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalog of over 100 drugs and commonly used drug regimens—both on- and off-label—for the treatment of all the major cancers. Special features: • Revised to reflect rapid advances in the field, incorporating treatment strategies and new drugs like brentuximab, carfilzomib, crizotinib, pertuzumab, rogorafenib, vemurafenib, and vismodegib. • A specific chapter focused on profiling antiemetic drug and antiemetic treatment regimens. • Diagrams of drug structures and pathways for many of the agents. • Offers a comprehensive discussion of clinical pharmacology, special considerations, indications, and dosages. • Covers toxicity and drug–drug interactions. • A section on chemotherapy regimens for all major cancers. • Provides an overview of the basic principles of cancer drug therapy. • Contains an easy to load and use CD version. Mobile version of Physicians’ Cancer Chemotherapy Drug Manual also available!